Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients
Marziyeh Ghorbani, Soha Namazi, Mehdi Dehghani, Farideh Razi, Bahman Khalvati, Ali Dehshahri
Springer Nature ·
2025-03-13
· DOI 10.1007/s10549-025-07674-x
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Marziyeh Ghorbani, Soha Namazi, Mehdi Dehghani, Farideh Razi, Bahman Khalvati, Ali Dehshahri. Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients. // Breast Cancer Research and Treatment. – 2025. – DOI: 10.1007/s10549-025-07674-x. – URL: https://doi.org/10.1007/s10549-025-07674-x
Marziyeh Ghorbani, Soha Namazi, Mehdi Dehghani, Farideh Razi, Bahman Khalvati, & Ali Dehshahri (2025). Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07674-x
Marziyeh Ghorbani, et al. “Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients.” Breast Cancer Research and Treatment, 2025. doi:10.1007/s10549-025-07674-x.
@article{Ghorbani2025,
title = {Identifying the potential mediators of pathological complete response to neoadjuvant chemotherapy among TACR1 gene polymorphisms: a study on breast cancer patients},
author = {Ghorbani, Marziyeh and Namazi, Soha and Dehghani, Mehdi and Razi, Farideh and Khalvati, Bahman and Dehshahri, Ali},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-025-07674-x},
url = {https://doi.org/10.1007/s10549-025-07674-x}
}